• Something wrong with this record ?

A randomised prospective double blind comparison of the use of intravenous or nebulised terbutaline in addition to standard treatment in the management of infective pulmonary exacerbations of cystic fibrosis (cf) [Randomised prospective double blind comparison of the use of intravenous or nebulised terbutaline in addition to standard treatment in the management of infective pulmonary exacerbations of cystic fibrosis (cf)]

M. J. FINNEGAN, D. V. HUGHES, M. E. HODSON

Language English Country Czech Republic

Document type Comparative Study

Randomised prospective double blind comparison of the use of intravenous or nebulised terbutaline in addition to standard treatment in the management of infective pulmonary exacerbations of cystic fibrosis (cf)

A randomised prospective double blind comparison of the use of intravenous or nebulised terbutaline in addition to standard treatment in the management of infective pulmonary exacerbations of cystic fibrosis (cf) = A randomised prospective double blind comparison of the use of intravenous or nebulised terbutaline in addition to standard treatment in the management of infective pulmonary exacerbations of cystic fibrosis (cf) /

000      
00000naa a2200000 a 4500
001      
bmc90009819
003      
CZ-PrNML
005      
20111209151625.0
008      
901000s1989 xr u eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Finnegan, M. J. $4 aut
245    12
$a A randomised prospective double blind comparison of the use of intravenous or nebulised terbutaline in addition to standard treatment in the management of infective pulmonary exacerbations of cystic fibrosis (cf) = $b A randomised prospective double blind comparison of the use of intravenous or nebulised terbutaline in addition to standard treatment in the management of infective pulmonary exacerbations of cystic fibrosis (cf) / $c M. J. FINNEGAN, D. V. HUGHES, M. E. HODSON
246    11
$a Randomised prospective double blind comparison of the use of intravenous or nebulised terbutaline in addition to standard treatment in the management of infective pulmonary exacerbations of cystic fibrosis (cf)
650    _2
$a cystická fibróza $x farmakoterapie $7 D003550
650    _2
$a plicní nemoci $x farmakoterapie $7 D008171
650    _2
$a terbutalin $x aplikace a dávkování $x farmakodynamika $7 D013726
650    _2
$a respirační funkční testy $7 D012129
650    _2
$a lidé $7 D006801
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Hughes, D. V. $4 aut
700    1_
$a Hodson, M. E. $4 aut
773    0_
$w MED00037147 $t 16th Annual meeting of the European Working Group for Cystic Fibrosis. [2] $g (1989), S. 192
910    __
$a ABA008 $b K 59580/2
990    __
$a 20060417
991    __
$a 20080103
BAS    __
$a 3
BMC    __
$a 1989 $d S. 192 $m 16th Annual meeting of the European Working Group for Cystic Fibrosis. [2] : abstract book $x MED00037147

Find record